Are routine fluids administered over the course of chemotherapy to maintain line patency prior to drugs separately reportable as hydration therapy?


Routine fluids administered during the course of chemotherapy to maintain line patency (KVO or TKO) prior to or between drugs or anti-neoplastics are not separately reported as hydration therapy.

This question was answered in our Coding Essentials for Infusion & Injection Therapy Services. For more hot topics relating to infusion services, please visit our store or call us at 1.800.252.1578, ext. 2.


CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.